Abstract
Radioactive-iodine (RAI) therapy is typically unprevailing as anaplastic thyroid cancer (ATC) management, owing to the decrease in the endogenous sodium iodide symporter (NIS) expression. Therefore, new strategies for NIS re-induction are required to improve the efficacy of RAI therapy in ATC. In this study, we developed a novel high-throughput NIS enhancer screening platform using a dual reporter gene system to identify a potent tyrosine kinase inhibitor (TKI) and selected a new hit compound, K905-0266 TKI. The effects of K905-0266 TKI treatment was validated as RAI accumulation, changes in signalling pathway related to thyroid pathogenesis, and cytotoxicity of RAI depending on re-induction of endogenous NIS expression in ATC. Furthermore, we evaluated enhancement of NIS promoter and therapeutic efficacy of RAI in ATC tumour xenograft mice. After K905-0266 TKI treatment, the expression of endogenous NIS was significantly increased, while phosphorylated-ERK was decreased. In addition, the thyroid-metabolising protein expressions were upregulated and increased of RAI accumulation and its therapeutic effects in ATC. Moreover, K905-0266 TKI increased therapeutic efficacy of RAI in ATC tumourin vivo. In conclusion, we successfully ...Continue Reading
References
Mar 17, 2000·Science·J Drews
Oct 2, 2001·Current Opinion in Chemical Biology·J M McDonnell
Oct 23, 2002·Clinical Endocrinology·Christine Spitzweg, John C Morris
Jul 10, 2003·Drug Discovery Today·Graeme Milligan
Jun 11, 2004·Journal of Biomedical Optics·S BhaumikS S Gambhir
Dec 17, 2004·Nature·Brian K Shoichet
Feb 11, 2005·Current Opinion in Chemical Biology·Mahesh UttamchandaniYoung-Tae Chang
Jun 1, 2006·Cancer Control : Journal of the Moffitt Cancer Center·Kepal N Patel, Ashok R Shaha
Mar 16, 2007·Assay and Drug Development Technologies·Frank Fan, Keith V Wood
Jul 20, 2007·Nature Chemical Biology·James IngleseDouglas S Auld
Nov 7, 2008·Endocrine-related Cancer·Robert C SmallridgeJohn A Copland
Feb 12, 2009·Proceedings of the National Academy of Sciences of the United States of America·Douglas S AuldJames Inglese
Dec 17, 2009·The Journal of Clinical Endocrinology and Metabolism·Peng HouMingzhao Xing
Jan 1, 2008·Biotechnology & Genetic Engineering Reviews·Tingting JiangJianghong Rao
Jul 27, 2011·Trends in Biotechnology·Christian E Badr, Bakhos A Tannous
Nov 23, 2011·The Journal of Clinical Investigation·Debyani ChakravartyJames A Fagin
Apr 28, 2012·Theranostics·Byeong-Cheol Ahn
Nov 14, 2012·Therapeutic Advances in Endocrinology and Metabolism·David A Liebner, Manisha H Shah
Feb 15, 2013·The New England Journal of Medicine·Alan L HoJames A Fagin
Jun 6, 2014·The Lancet. Diabetes & Endocrinology·Christine SpitzwegJohn C Morris
Mar 15, 2015·The Journal of Clinical Endocrinology and Metabolism·Maomei RuanLibo Chen
Sep 5, 2015·Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine·Thoudam Debraj SinghYoung Hyun Jeon
Dec 17, 2015·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·S Michael RothenbergLori J Wirth
May 31, 2016·BioMed Research International·Byeong-Cheol Ahn
Sep 15, 2016·The New England Journal of Medicine·James A Fagin, Samuel A Wells
Apr 21, 2017·Oncotarget·Lingxiao ChengLibo Chen
Jun 15, 2017·Asian Pacific Journal of Cancer Prevention : APJCP·Enas Younis
Nov 1, 2017·Frontiers in Endocrinology·Chae Moon Hong, Byeong-Cheol Ahn
Citations
Jan 14, 2020·Thyroid : Official Journal of the American Thyroid Association·Ji Min OhByeong-Cheol Ahn
Mar 20, 2020·Journal of Drug Targeting·Senthilkumar KalimuthuByeong-Cheol Ahn
Aug 6, 2020·Cancers·Mohammad Al-JundiJoanna Klubo-Gwiezdzinska
Dec 10, 2020·Scientific Reports·Hassan Rakhsh-KhorshidVahid Haghpanah
Nov 24, 2019·The Science of the Total Environment·Eman T MohammedMohamed M Abdel-Daim
Jul 9, 2021·The Journal of Clinical Investigation·Young Ah LeeYoung Joo Park